Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spin out of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Our lawyers represented a venture capital fund in its collaboration with a publicly traded Dutch company and a US executive in developing a web-based gaming site in the United Kingdom.

RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Publications

January 31, 2024

Massachusetts Taxation and DOR Practice Guide

Read More

Publications

January 31, 2024

Adult-Use Cannabis Licensing (MA)

Read More

Speaking Engagements

January 18, 2024

Business Immigration Fundamentals

Read More

Firm Announcements

December 19, 2023

Davis Malm Attorneys Serve as Contributing Authors for ILN’s 2023 Edition of “Establishing a Business Entity: An International Guide”

Read More

Speaking Engagements

December 11, 2023

2023 Massachusetts State Tax Update

Read More

Alerts

December 5, 2023

Be Prepared as the Corporate Transparency Act (CTA) Takes Effect January 1, 2024

Read More

Alerts

November 29, 2023

Highlights of the New Massachusetts Rules Implementing the Cannabis Act

Read More

Publications

November 1, 2023

Massachusetts State and Local Tax Update – Third Quarter 2023

Read More

Speaking Engagements

October 26, 2023

Forming a Company

Read More

Contact Us

Need Business Counsel?

Get in touch
Scroll to Top